EUVIMEDEUVIMED entdecken
Crossref

Legal Analysis of the Legal Protection of Patients Participating in New Drug Clinical Trials

E.Nasution, F.Alamsyah

The Medical Journal of Hospital Management and Health Law · 01.01.2026 · 2 (2)

DOI: 10.70070/9xm5a589 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Medical Journal of Hospital Management and Health Law, online erschienen am 01.01.2026. Verfasst von E.Nasution und 1 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

The rapid development of pharmaceutical biotechnology necessitates clinical trials on human subjects to ensure drug safety and efficacy, yet this process inherently exposes patient-participants to severe health risks and potential exploitation. This study examines the adequacy of current legal frameworks in safeguarding human subjects during clinical trials of new investigational drugs.

Methods

This study employs a normative juridical research method, analyzing primary, secondary, and tertiary legal materials, including international guidelines, national healthcare statutes, and consumer protection regulations.

Results

The analysis reveals that while basic regulatory frameworks exist, significant legal vacuums remain regarding strict liability for clinical trial injuries, the enforceability of informed consent under asymmetric medical relationships, and comprehensive institutional oversight mechanisms.

Discussion

The discussion comprehensively integrates a literature review regarding patient autonomy, bioethics, and state responsibility, highlighting how the unequal bargaining power between pharmaceutical sponsors and vulnerable patients undermines genuine consent. It evaluates the legal nature of clinical trial agreements, identifying them as adhesion contracts that require intervention through mandatory indemnification clauses and enhanced Institutional Review Board oversight.

Conclusions

Current legal protections are fragmented and insufficient to address the complexities of modern clinical trials, necessitating a shift toward robust statutory strict liability and standardized operational protocols. It is recommended that the legislature enact a dedicated statute governing clinical trials and that healthcare authorities establish a mandatory state-backed insurance scheme to provide immediate compensation for injured participants without the burden of proving negligence.

Zitieren

APA

E.Nasution, & F.Alamsyah (2026). Legal Analysis of the Legal Protection of Patients Participating in New Drug Clinical Trials. The Medical Journal of Hospital Management and Health Law, 2(2). https://doi.org/10.70070/9xm5a589

Vancouver

E.Nasution, F.Alamsyah. Legal Analysis of the Legal Protection of Patients Participating in New Drug Clinical Trials. The Medical Journal of Hospital Management and Health Law. 2026;2(2). doi:10.70070/9xm5a589

BibTeX
@article{ENasution2026,
  author = {E.Nasution and F.Alamsyah},
  title = {Legal Analysis of the Legal Protection of Patients Participating in New Drug Clinical Trials},
  journal = {The Medical Journal of Hospital Management and Health Law},
  year = {2026},
  volume = {2},
  number = {2},
  doi = {10.70070/9xm5a589}
}
Kostenlos starten →